Search results for "ORIGINAL ARTICLES"

showing 10 items of 474 documents

Patient-Reported Nonadherence with Glaucoma Therapy

2019

Abstract Purpose: Effective glaucoma therapy relies to a great extent on the patients' ability to regularly self-administer eye drops. This study aimed to assess self-reported nonadherence and to identify potential barriers to adherence in glaucoma patients. Methods: Participants completed a 16-item questionnaire, designed to examine nonadherence rate and assess the therapy experience. Inclusion criteria stipulated treatment duration of at least 1 year. Nonadherence was defined as missing ≥5% of the prescribed pressure-lowering eye drops doses. Results: In total, 201 glaucoma patients aged 24–88 years were included. Mean treatment duration was 9.4 years. Nonadherence was reported by 30.3% o…

AdultMalemedicine.medical_specialtygenetic structuresGlaucomaoutcomesYoung AdultGermanySurveys and QuestionnairesmedicineHumansPharmacology (medical)adherencePatient Reported Outcome MeasuresIntensive care medicineAntihypertensive AgentsAgedPharmacologyAged 80 and overnonadherencebusiness.industryPreservatives PharmaceuticalGlaucomaOriginal ArticlesMiddle Agedmedicine.diseaseeye diseasesOphthalmologyside effectsPatient ComplianceFemalesense organspreservativesInjections IntraocularOphthalmic SolutionsbusinessJournal of Ocular Pharmacology and Therapeutics
researchProduct

T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

2005

SummaryHuman parvovirus B19 is a small non-enveloped DNA virus with an icosahedral capsid consisting of proteins of only two species, the major protein VP2 and the minor protein VP1. VP2 is contained within VP1, which has an additional unique portion (VP1u) of 227 amino acids. We determined the ability of eukaryotically expressed parvovirus B19 virus-like particles consisting of VP1 and VP2 in the ratio recommended for vaccine use, or of VP2 alone, to stimulate, in an HLA class II restricted manner, peripheral blood mononuclear cells (PBMC) to proliferate and to secrete interferon gamma (IFN-γ) and interleukin (IL)-10 cytokines among recently and remotely B19 infected subjects. PBMC reactiv…

AdultMalevirusesImmunologyPeripheral blood mononuclear cellVirusParvoviridae Infections03 medical and health sciencesEpitopesInterferon-gammaAntigenPregnancymedicineParvovirus B19 HumanImmunology and AllergyHumansInterferon gammaPregnancy Complications InfectiousCells Cultured030304 developmental biologyParvoviridae0303 health sciencesImmunity Cellularbiology030306 microbiologyParvovirusHistocompatibility Antigens Class IIInterleukinvirus diseasesT helper cellT-Lymphocytes Helper-InducerOriginal ArticlesMiddle Agedbiology.organism_classificationVirology3. Good healthInterleukin-10Endotoxinsmedicine.anatomical_structureImmunologyLeukocytes MononuclearCapsid ProteinsFemaleCell Divisionmedicine.drugClinical and experimental immunology
researchProduct

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by E…

2011

Background: The Gruppo Oncologico Italia Meridionale 9902 trial compared four cycles of high-dose epirubicin plus cyclophosphamide (EC) with four cycles of docetaxel (Taxotere, D) followed by four cycles of EC as adjuvant treatment of node-positive breast cancer. Patients and methods: Patients were randomly assigned to EC (E 120 mg/m 2 , C 600 mg/m 2 , arm A) for four cycles or four cycles of D (100 mg/m 2 ) followed by four cycles of EC (arm B), both regimens every 21 days. Hormone receptor-positive patients were given hormonal therapy for 5 years. Primary end point was 5-year disease-free survival (DFS). Secondary objectives were overall survival (OS) and safety. Results: There were 750 p…

AdultOncologymedicine.medical_specialtyCyclophosphamideBreast NeoplasmsDocetaxelDisease-Free SurvivalBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesProspective cohort studyCyclophosphamideSurvival analysisEpirubicinGynecologyDose-Response Relationship Drugbusiness.industryCarcinomaHazard ratioOriginal ArticlesHematologyMiddle Agedmedicine.diseaseSurvival AnalysisItalyOncologyDocetaxelLymphatic MetastasisHormonal therapyFemaleTaxoidsLymph NodesbusinessAlgorithmsmedicine.drugEpirubicinAnnals of Oncology
researchProduct

Assessment of maximal handgrip strength: How many attempts are needed?

2017

BACKGROUND: Handgrip strength (HGS) is used to identify individuals with low muscle strength (dynapenia). The influence of the number of attempts on maximal HGS is not yet known and may differ depending on age and health status. This study aimed to assess how many attempts of HGS are required to obtain maximal HGS.METHODS: Three cohorts (939 individuals) differing in age and health status were included. HGS was assessed three times and explored as continuous and dichotomous variable. Paired t-test, intraclass correlation coefficients (ICC) and Bland-Altman analysis were used to test reproducibility of HGS. The number of individuals with misclassified dynapenia at attempts 1 and 2 with respe…

AdultSarcopeniaAdolescentsex differenceHealth Statusadult; aged; aging; Article; cohort analysis; dual energy X ray absorptiometry; dynamometer; female; four minute walk test; geriatric assessment; grip strength; health status; human; major clinical study; male; middle aged; muscle strength; outpatient; priority journal; reproducibility; sarcopenia; sex difference; six minute walk test; walk test; walking speed; X ray bone densitometer; Aged; Geriatric assessment; Muscle strength; Reproducibility of Results; Sarcopeniahealth statuswalking speedArticlesarcopeniaCohort StudiesYoung Adultmalesix minute walk testmiddle aged80 and overHumansfour minute walk testhumanMuscle StrengthreproducibilityGeriatric AssessmentX ray bone densitometerAgedAged 80 and overdual energy X ray absorptiometryHand StrengthMuscle strengthadultwalk testagingAge FactorsReproducibility of ResultsOriginal ArticlesdynamometerMiddle Agedcohort analysismajor clinical studyGeriatric assessmentfemaleCross-Sectional Studiespriority journalgrip strengthoutpatientOriginal Articlelihasvoima
researchProduct

Heat shock protein-27 protects human bronchial epithelial cells against oxidative stress-mediated apoptosis: possible implication in asthma.

2002

Inflammation of the human bronchial epithelium, as observed in asthmatics, is characterized by the selective death of the columnar epithelial cells, which desquamate from the basal cells. Tissue repair initiates from basal cells that resist inflammation. Here, we have evaluated the extent of apoptosis as well as the Hsp27 level of expression in epithelial cells from bronchial biopsy samples taken from normal and asthmatic subjects. Hsp27 is a chaperone whose expression protects against oxidative stress. We report that in asthmatic subjects the basal epithelium cells express a high level of Hsp27 but no apoptotic morphology. In contrast, apoptotic columnar cells are devoid of Hsp27 expressio…

Adultendocrine systemanimal structuresHSP27 Heat-Shock ProteinsInflammationApoptosisBronchiColumnar CellRespiratory MucosaBiologymedicine.disease_causeBiochemistryGene Expression Regulation EnzymologicHsp27Heat shock proteinmedicineBronchial BiopsyHumansHeat-Shock ProteinsEpithelial CellsCell BiologyHydrogen PeroxideOriginal ArticlesMiddle AgedOxidantsEpitheliumAsthmaCell biologyNeoplasm ProteinsOxidative Stressmedicine.anatomical_structureApoptosisImmunologybiology.proteinmedicine.symptomOxidative stressMolecular ChaperonesCell stresschaperones
researchProduct

Evaluation of appendicitis risk prediction models in adults with suspected appendicitis.

2019

Background Appendicitis is the most common general surgical emergency worldwide, but its diagnosis remains challenging. The aim of this study was to determine whether existing risk prediction models can reliably identify patients presenting to hospital in the UK with acute right iliac fossa (RIF) pain who are at low risk of appendicitis. Methods A systematic search was completed to identify all existing appendicitis risk prediction models. Models were validated using UK data from an international prospective cohort study that captured consecutive patients aged 16–45 years presenting to hospital with acute RIF in March to June 2017. The main outcome was best achievable model specificity (pro…

AdulthumanosDecision MakingRisk AssessmentNOapendicectomíaapendicitisevaluación de riesgosAppendectomyHumanshospitalGeneralcollaborativeLS7_4right iliac fossa; appendicitis; collaborativeemergency serviceOriginal Articlesadultoright iliac fossaAppendicitisadult; appendectomy; appendicitis; humans; risk assessment; decision making; emergency service; hospitalLower GIOriginal Articleappendicitis prediction models right iliac fossa painEmergency Service Hospitaltoma de decisiónThe British journal of surgery
researchProduct

Ventricular Tachycardia and Early Fibrillation in Patients With Brugada Syndrome and Ischemic Cardiomyopathy Show Predictable Frequency-Phase Propert…

2015

[EN] Background¿ Ventricular fibrillation (VF) has been proposed to be maintained by localized high-frequency sources. We tested whether spectral-phase analysis of the precordial ECG enabled identification of periodic activation patterns generated by such sources. Methods and Results¿Precordial ECGs were recorded from 15 ischemic cardiomyopathy and 15 Brugada syndrome (type 1 ECG) patients during induced VF and analyzed in the frequency-phase domain. Despite temporal variability, induced VF episodes lasting 19.6±7.9 s displayed distinctly high power at a common frequency (shared frequency, 5.7±1.1 Hz) in all leads about half of the time. In patients with Brugada syndrome, phase analysis of …

Adultmedicine.medical_specialty5electrocardiographyInfarctionVentricular tachycardiaTECNOLOGIA ELECTRONICAElectrocardiographyPhysiology (medical)Internal medicinemedicineHumansBrugada syndromeMyocardial infarctioncardiovascular diseasesVentricular fibrillationBrugada syndromeAgedFibrillationIschemic cardiomyopathymedicine.diagnostic_testbusiness.industry106Original ArticlesMiddle Agedmedicine.diseaseventricular fibrillationMyocardial infarctionmyocardial infarctionVentricular TachycardiaAnesthesiaVentricular fibrillationCardiologyComputingMethodologies_DOCUMENTANDTEXTPROCESSINGTachycardia Ventricularmedicine.symptomCardiology and Cardiovascular MedicinebusinessCardiomyopathiesElectrophysiologic Techniques CardiacElectrocardiography
researchProduct

The role of regulatory T cell (Treg) subsets in gestational diabetes mellitus.

2014

Physiological changes during normal pregnancy are characterized by an inflammatory immune response and insulin resistance. Therefore, we hypothesize that gestational diabetes mellitus (GDM) may be caused by an inappropriate adaption of the maternal immune system to pregnancy. In this study we examined the role of regulatory T cell (Treg) differentiation for the development of GDM during pregnancy. We used six-colour flow cytometric analysis to demonstrate that the total CD4(+) CD127(low+/-) CD25(+) forkhead box protein 3 (FoxP3(+)) T(reg) pool consists of four different T(reg) subsets: naive CD45RA(+) T(regs), HLA-DR(-) CD45RA(-) memory T(regs) (DR(-) T(regs)) and the highly differentiated …

Adultmedicine.medical_specialtyendocrine system diseasesRegulatory T cellImmunologychemical and pharmacologic phenomenaCell SeparationLymphocyte ActivationT-Lymphocytes RegulatoryImmunophenotypingYoung AdultImmune systemInsulin resistanceimmune system diseasesPregnancyT-Lymphocyte Subsetshemic and lymphatic diseasesInternal medicinemedicineImmune ToleranceImmunology and AllergyHomeostasisHumansIL-2 receptorInterleukin-7 receptorbusiness.industryFOXP3hemic and immune systemsCell DifferentiationForkhead Transcription FactorsT helper cellOriginal Articlesmedicine.diseaseFlow CytometryGestational diabetesDiabetes GestationalEndocrinologymedicine.anatomical_structureImmunologyCD4 AntigensFemalebusinessImmunologic MemoryClinical and experimental immunology
researchProduct

IL-15 in human visceral leishmaniasis caused byLeishmania infantum

2002

SummaryInterleukin (IL)-15 is a recently discovered cytokine with the ability to stimulate the proliferation activity of Th1 and/or Th2 lymphocytes. Here, we investigated the involvement of IL-15 in the immune response to Leishmania infantum infection by studying patients with visceral leishmaniasis (VL). We found that IL-15 is produced by leishmanial antigen (LAg)-stimulated peripheral blood mononuclear cells (PBMC) from active VL patients at a significantly higher level than those produced by cells from healed VL subjects or healthy controls. A significant increase in IL-15 serum blood levels was also observed in acute VL patients compared with healed ones. Furthermore, recombinant IL-15 …

Adultmedicine.medical_treatmentImmunologyAntigens ProtozoanLymphocyte ActivationInterferon-gammaTh2 CellsAntigenmedicineAnimalsHumansImmunology and AllergyLeishmania infantumInterleukin-15biologyAntibodies MonoclonalInterleukinOriginal ArticlesTh1 Cellsbiology.organism_classificationmedicine.diseaseInterleukin-12Recombinant ProteinsCytokineVisceral leishmaniasisInterleukin 15ImmunologyLeukocytes MononuclearInterleukin 12Leishmaniasis VisceralInterleukin-4Leishmania infantumCell activationClinical and Experimental Immunology
researchProduct

Clinical and radiographic performance of self‐locking conical connection implants in the posterior mandible: Five‐year results of a two‐centre prospe…

2021

Abstract Objective This prospective study aims to assess the 5‐year clinical performance of implants with internal conical connection and platform‐switched abutments in the posterior mandible. Material and Methods Healthy adults missing at least two teeth in the posterior mandible and with a natural tooth mesial to the implant site received two or three adjacent implants. After a transmucosal healing period single crown restorations were cemented on platform‐switched abutments. Changes in marginal bone levels were investigated in standardized periapical radiographs from surgery and loading (baseline) to 60‐months post‐loading. Results Twenty‐four patients received 52 implants. Bone remodell…

Adultmedicine.medical_treatmentRadiographyAlveolar Bone LossDentistryMandibleProsthesisBone remodelingmedicineHumansProspective StudiesProspective cohort studyDental implantplatform switchDental ImplantsPosterior mandibleBone preservationdental implantbusiness.industrybone levelOriginal Articlesconical connection implantsDental Prosthesis DesignoutcomeOriginal ArticleImplantDental Prosthesis Implant-SupportedOral Surgerybusinessbone remodellingFollow-Up StudiesClinical Oral Implants Research
researchProduct